Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. [Phase 3]
Phase 3 trial update investigating low molecular weight heparin (LMWH) for preventing thromboembolic complications after transarterial chemo…
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis [Phase 4]
A Phase 4 trial comparing surgery with sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) [Phase 2]
Phase 2 clinical trial evaluating concurrent transarterial chemoembolization (TACE) and sorafenib for hepatocellular carcinoma with metastas…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma [Phase 3]
A Phase 3 study evaluating an all-oral regimen of ombitasvir/paritaprevir/ritonavir with or without dasabuvir and with or without ribavirin …
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Metabolic Signature of Healthy Lifestyle and HCC
Clinical trial NCT03356535, sponsored by the International Agency for Research on Cancer, has completed a study examining the metabolic sign…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium [NA]
A completed clinical trial evaluating functional MRI in patients with hepatocellular carcinoma treated with Yttrium-90.
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: 11C-acetate for Treatment Response After Radiotherapy for HCC [Phase 2]
Phase 2 study evaluating 11C-acetate as an imaging biomarker to assess treatment response after radiotherapy in hepatocellular carcinoma was…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Primary Liver Cancer [Phase 2]
Phase 2 trial of antineoplaston therapy for hepatocellular carcinoma was terminated. No efficacy results are provided.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Phase I Study of Pazopanib in Adult Patients With Liver Cancer [Phase 1]
Phase I trial evaluating pazopanib in adults with hepatocellular carcinoma has been completed, focusing on safety, tolerability, and dosing.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Caphosol in Oral Mucositis Due to Targeted Therapy [Phase 3]
A Phase 3 trial evaluating Caphosol for oral mucositis caused by targeted cancer therapies has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Residual Plasma Concentration of Sorafenib and Adverse Events in CHC
The update discusses residual plasma concentrations of sorafenib and related adverse events in patients with advanced or metastatic hepatoce…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Pembrolizumab as Neoadjuvant Treatment in HCC [Phase 2]
Phase 2 trial assessing pembrolizumab as neoadjuvant therapy for hepatocellular carcinoma. Sponsor: Kindai University; current trial status …
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) [Phase 2]
A completed Phase 2 clinical trial evaluated the combination of oblimersen and doxorubicin in patients with advanced hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma [Phase 3]
Phase 3 trial of ONCO-DOX in locally advanced hepatocellular carcinoma was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) [Phase 2]
The HepSTAR Phase 2 trial comparing TACE alone versus TACE plus SABR for BCLC stage B hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib [Phase 2]
A Phase 2 trial evaluating the combination of transcatheter arterial chemoembolization (TACE) and sorafenib for hepatocellular carcinoma, in…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT
This update reports observed changes in liver function after stereotactic body radiation therapy in patients with hepatocellular carcinoma o…
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: DEB-TACE Treatment in 367 Liver Cancer Patients
A completed clinical trial evaluating drug-eluting bead transarterial chemoembolization (DEB-TACE) with doxorubicin in hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA). [Phase 1, Phase 2]
A phase 1/2 trial of MASCT (Multiple Antigen Specific Cell Therapy) for hepatocellular carcinoma after radical resection or radiofrequency a…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) [Phase 3]
A randomized, double-blind, placebo-controlled Phase III trial evaluating tivantinib (ARQ-197) in hepatocellular carcinoma has completed in …
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy [Phase 4]
Phase 4 clinical trial update on Huaier Granule for prevention of recurrence and metastasis after radical hepatectomy in hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated belinostat in adults with unresectable or advanced primary liver cancers, including hepatocellular …
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. [NA]
Clinical trial update assessing liver cancer response to transarterial chemoembolization (TACE) using MultiHance-enhanced MRI in hepatocellu…
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma [Phase 2]
A Phase 2 trial evaluating the combination of sorafenib and pravastatin for advanced hepatocarcinoma has completed, reporting efficacy and s…